HIV/AIDS: in search of an animal model

Trends in Biotechnology

Volumn 25, Issue 8, 2007, Pages 333-337

  Ambrose, Zandrea ^a   KewalRamani, Vineet N ^a   Bieniasz, Paul D ^b   Hatziioannou, Theodora ^b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b ROCKEFELLER UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL MODELS; ANTIRETROVIRAL THERAPIES; HUMAN IMMUNODEFICIENCY VIRUS;

IMMUNOLOGY; MATHEMATICAL MODELS; PHYSICAL THERAPY; VIRUSES;

DISEASES;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; EXPERIMENTAL INFECTION; EXPERIMENTAL MODEL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MEDICAL RESEARCH; NONHUMAN; PRIORITY JOURNAL; SIMIAN IMMUNODEFICIENCY VIRUS;

ANIMALS; DISEASE MODELS, ANIMAL; HIV INFECTIONS; HUMANS; LENTIVIRUS;

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS 1; MACACA MULATTA; SIMIAN IMMUNODEFICIENCY VIRUS;

EID: 34447280883     PISSN: 01677799     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tibtech.2007.05.004     Document Type: Article

References (50)

1. Mosier D.E., et al. Human immunodeficiency virus infection of human-PBL-SCID mice. Science 251 (1991) 791-794
2. McCune J.M., et al. Suppression of HIV infection in AZT-treated SCID-hu mice. Science 247 (1990) 564-566
3. -/- mice. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 15951-15956
4. Gardner M.B., and Luciw P.A. Animal models of AIDS. FASEB J. 3 (1989) 2593-2606
5. Ohta Y., et al. Isolation of simian immunodeficiency virus from African green monkeys and seroepidemiologic survey of the virus in various non-human primates. Int. J. Cancer 41 (1988) 115-122
6. Brenchley J.M., et al. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat. Med. 12 (2006) 1365-1371
7. Schindler M., et al. Nef-mediated suppression of T cell activation was lost in a lentiviral lineage that gave rise to HIV-1. Cell 125 (2006) 1055-1067
8. Daniel M.D., et al. Isolation of T-cell tropic HTLV-III-like retrovirus from macaques. Science 228 (1985) 1201-1204
9. Letvin N.L., et al. Induction of AIDS-like disease in macaque monkeys with T-cell tropic retrovirus STLV-III. Science 230 (1985) 71-73
10. Naidu Y.M., et al. Characterization of infectious molecular clones of simian immunodeficiency virus (SIVmac) and human immunodeficiency virus type 2: persistent infection of rhesus monkeys with molecularly cloned SIVmac. J. Virol. 62 (1988) 4691-4696
11. Kestler III H.W., et al. Use of infectious molecular clones of simian immunodeficiency virus for pathogenesis studies. J. Med. Primatol. 18 (1989) 305-309
12. Benveniste R.E., et al. Inoculation of baboons and macaques with simian immunodeficiency virus/Mne, a primate lentivirus closely related to human immunodeficiency virus type 2. J. Virol. 62 (1988) 2091-2101
13. Lewis M.G., et al. Infection of rhesus and cynomolgus macaques with a rapidly fatal SIV (SIVSMM/PBj) isolate from sooty mangabeys. AIDS Res. Hum. Retrov. 8 (1992) 1631-1639
14. Kestler III H.W., et al. Importance of the nef gene for maintenance of high virus loads and for development of AIDS. Cell 65 (1991) 651-662
15. Whatmore A.M., et al. Repair and evolution of nef in vivo modulates simian immunodeficiency virus virulence. J. Virol. 69 (1995) 5117-5123
16. McClure H.M., et al. Maternal transmission of SIVsmm in rhesus macaques. J. Med. Primatol. 20 (1991) 182-187
17. Miller C.J., et al. Genital mucosal transmission of simian immunodeficiency virus: animal model for heterosexual transmission of human immunodeficiency virus. J. Virol. 63 (1989) 4277-4284
18. Pauza C.D., et al. Pathogenesis of SIVmac251 after atraumatic inoculation of the rectal mucosa in rhesus monkeys. J. Med. Primatol. 22 (1993) 154-161
19. Spira A.I., et al. Cellular targets of infection and route of viral dissemination after an intravaginal inoculation of simian immunodeficiency virus into rhesus macaques. J. Exp. Med. 183 (1996) 215-225
20. Heise C., et al. Distribution of SIV infection in the gastrointestinal tract of rhesus macaques at early and terminal stages of AIDS. J. Med. Primatol. 22 (1993) 187-193
21. + T lymphocytes from effector sites in the gastrointestinal tract. J. Exp. Med. 200 (2004) 761-770
22. + T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract. J. Exp. Med. 200 (2004) 749-759
23. Daniel M.D., et al. Protective effects of a live attenuated SIV vaccine with a deletion in the nef gene. Science 258 (1992) 1938-1941
24. Daniel M.D., et al. High-titer immune responses elicited by recombinant vaccinia virus priming and particle boosting are ineffective in preventing virulent SIV infection. AIDS Res. Hum. Retrov. 10 (1994) 839-851
25. Ahmad S., et al. Reduced virus load in rhesus macaques immunized with recombinant gp160 and challenged with simian immunodeficiency virus. AIDS Res. Hum. Retrov. 10 (1994) 195-204
26. Uberla K., et al. Animal model for the therapy of acquired immunodeficiency syndrome with reverse transcriptase inhibitors. Proc. Natl. Acad. Sci. U.S.A. 92 (1995) 8210-8214
27. Pantophlet R., and Burton D.R. GP120: target for neutralizing HIV-1 antibodies. Annu. Rev. Immunol. 24 (2006) 739-769
28. Yuste E., et al. Simian immunodeficiency virus engrafted with human immunodeficiency virus type 1 (HIV-1)-specific epitopes: replication, neutralization, and survey of HIV-1-positive plasma. J. Virol. 80 (2006) 3030-3041
29. Shibata R., et al. Generation of a chimeric human and simian immunodeficiency virus infectious to monkey peripheral blood mononuclear cells. J. Virol. 65 (1991) 3514-3520
30. Li J., et al. Infection of cynomolgus monkeys with a chimeric HIV-1/SIVmac virus that expresses the HIV-1 envelope glycoproteins. J. Acq. Immun. Def. Synd. 5 (1992) 639-646
31. Reimann K.A., et al. A chimeric simian/human immunodeficiency virus expressing a primary patient human immunodeficiency virus type 1 isolate env causes an AIDS-like disease after in vivo passage in rhesus monkeys. J. Virol. 70 (1996) 6922-6928
32. Luciw P.A., et al. Persistent infection of rhesus macaques with T-cell-line-tropic and macrophage-tropic clones of simian/human immunodeficiency viruses (SHIV). Proc. Natl. Acad. Sci. U. S. A. 92 (1995) 7490-7494
33. Etemad-Moghadam B., et al. Characterization of simian-human immunodeficiency virus envelope glycoprotein epitopes recognized by neutralizing antibodies from infected monkeys. J. Virol. 72 (1998) 8437-8445
34. Montefiori D.C., et al. Neutralizing antibodies in sera from macaques infected with chimeric simian-human immunodeficiency virus containing the envelope glycoproteins of either a laboratory-adapted variant or a primary isolate of human immunodeficiency virus type 1. J. Virol. 72 (1998) 3427-3431
35. Baba T.W., et al. Human neutralizing monoclonal antibodies of the IgG1 subtype protect against mucosal simian-human immunodeficiency virus infection. Nat. Med. 6 (2000) 200-206
36. Mascola J.R., et al. Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies. Nat. Med. 6 (2000) 207-210
37. Shibata R., et al. Neutralizing antibody directed against the HIV-1 envelope glycoprotein can completely block HIV-1/SIV chimeric virus infections of macaque monkeys. Nat. Med. 5 (1999) 204-210
38. Amara R.R., et al. Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine. Science 292 (2001) 69-74
39. Belyakov I.M., et al. Mucosal AIDS vaccine reduces disease and viral load in gut reservoir and blood after mucosal infection of macaques. Nat. Med. 7 (2001) 1320-1326
40. SF162P3. J. Virol. 75 (2001) 1990-1995
41. Song R.J., et al. Molecularly cloned SHIV-1157ipd3N4: a highly replication- competent, mucosally transmissible R5 simian-human immunodeficiency virus encoding HIV clade C env. J. Virol. 80 (2006) 8729-8738
42. Lederman M.M., et al. Prevention of vaginal SHIV transmission in rhesus macaques through inhibition of CCR5. Science 306 (2004) 485-487
43. Ambrose Z., et al. In vitro characterization of a simian immunodeficiency virus-human immunodeficiency virus (HIV) chimera expressing HIV type 1 reverse transcriptase to study antiviral resistance in pigtail macaques. J. Virol. 78 (2004) 13553-13561
44. Pekrun K., et al. Evolution of a human immunodeficiency virus type 1 variant with enhanced replication in pig-tailed macaque cells by DNA shuffling. J. Virol. 76 (2002) 2924-2935
45. Shibata R., and Adachi A. SIV/HIV recombinants and their use in studying biological properties. AIDS Res. Hum. Retrov. 8 (1992) 403-409
46. Sheehy A.M., et al. Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein. Nature 418 (2002) 646-650
47. Stremlau M., et al. The cytoplasmic body component TRIM5α restricts HIV-1 infection in Old World monkeys. Nature 427 (2004) 848-853
48. Bieniasz P.D. Intrinsic immunity: a front-line defense against viral attack. Nat. Immunol. 5 (2004) 1109-1115
49. Hatziioannou T., et al. Generation of simian-tropic HIV-1 by restriction factor evasion. Science 314 (2006) 95
50. Kamada K., et al. Generation of HIV-1 derivatives that productively infect macaque monkey lymphoid cells. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 16959-16964